ABIONYX Pharma SA (EPA:ABNX)
France · Delayed Price · Currency is EUR 1.604
-0.040 (-2.43%)
Oct 22, 2026, 5:35 PM CEST
ABIONYX Pharma Market Cap
ABIONYX Pharma has a market cap or net worth of €67.91 million as of October 22, 2026. It is the 27,048th most valuable company in the world and the 337th biggest in France. Its market cap has decreased by 38.03% in one year.
Market Cap
67.91M
Enterprise Value
68.19M
Revenue
4.06M
Global Rank
Country Rank
#337 France
PE Ratio
n/a
ChartMarket Cap Chart
Since March 30, 2015, ABIONYX Pharma's market cap has decreased from 214.16M to 67.91M, a decrease of -68.29%. That is a compound annual growth rate of -9.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 67.91M | -49.14% |
| Dec 31, 2025 | 133.53M | 223.58% |
| Dec 31, 2024 | 41.27M | -0.54% |
| Dec 29, 2023 | 41.49M | -14.37% |
| Dec 30, 2022 | 48.45M | -28.38% |
| Dec 31, 2021 | 67.65M | 178.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Valerio Therapeutics Société anonyme | 205.27M |
| Transgene | 186.79M |
| Innate Pharma | 126.50M |
| Sensorion | 95.93M |
| Cellectis | 69.03M |
| OSE Immunotherapeutics | 49.39M |
| Adocia | 48.94M |
| THX Pharma Société Anonyme | 47.70M |